Publications by authors named "Saud M Elsaughier"
Article Synopsis
- Heart failure is a leading cause of hospitalizations in elderly patients, particularly those with diabetes, who may have increased risk factors for heart function decline.
- A study assessed the impact of adding dapagliflozin to furosemide in 100 type 2 diabetic patients with decompensated heart failure, focusing on outcomes like weight loss and improvement in dyspnea.
- Results showed significant benefits from dapagliflozin in terms of weight and fluid loss, along with better patient-reported breathing scores, without affecting kidney function or potassium levels.
Background: Patent ductus arteriosus (PDA) causes volume overload of the left side of the heart. Stiffening in the larger central arterial system, such as the aortic tree, significantly contributes to cardiovascular diseases in older individuals and is positively associated with systolic hypertension and coronary artery disease. In this study, we evaluated the effect of time delay of PDA closure on aortic stiffness and its relationship with cardiac function before and after transcatheter closure of the PDA.
View Article and Find Full Text PDFBackground: Patent ductus arteriosus is generally associated with hyperdynamic status. Given the vascular shunt between the aorta and pulmonary artery, intrinsic aortic changes occur (aortic stiffness). In the present study, we attempted to assess the impact of PDA on aortic stiffness and its connection with cardiovascular function before and after transcatheter closure of PDA.
View Article and Find Full Text PDF